Taiwan FDA registration be56a32e5fb5e9bb24ac354e78197f99
Edadis double-stranded DNA IgG antibody test group
TW: 埃達堤斯雙股去氧核糖核酸IgG抗體檢驗組
Taiwan·Risk Class 2·ADALTIS ITALY S.P.A.;; ADALTIS ITALIA SPA·Registered Jan 25, 2007 – Jan 25, 2012CancelledRegistration details
- Analysis ID
- be56a32e5fb5e9bb24ac354e78197f99
- Customs Code
- DHA00601789008
Company information
- Manufacturer
- ADALTIS ITALY S.P.A.;; ADALTIS ITALIA SPA
- Manufacturer Country
- Italy
- Authorized Representative
- Ariel Health Inc
Product details
- Intended Use
- 利用酵素連結的免疫吸附分析法(enzyme-linked immunosorbent assay method),定量檢測人類血清中,對抗雙股去氧核糖核酸的特定IgG自體抗體.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5510 免疫球蛋白A,G,M,D及E免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Jan 25, 2007
- Expiry Date
- Jan 25, 2012
- Cancellation Date
- Apr 16, 2014
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Edadis double-stranded DNA IgG antibody test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number be56a32e5fb5e9bb24ac354e78197f99 and manufactured by ADALTIS ITALY S.P.A.;; ADALTIS ITALIA SPA. The authorized representative in Taiwan is Ariel Health Inc.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices